PF
PAX Financial Group, LLC
13F filer · CIK 0001803673Reported Aug 5, 2026
Net buyer this quarter
13F portfolio value$673MU.S. long equity reported on 13F
Positions11519 new · 14 closed
Net flow last quarter+$1.62MBuys minus sells
Top 10 positions weight7.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 5, 2026115 positions | |||||
| $9.04M | 1.34% | 2.65% | -31.5% | Q2 2025 | |
| $6.76M | 1.00% | Not reported | -1.9% | Q4 2019 | |
| $5.95M | 0.88% | 0.00% | +5.4% | Q4 2019 | |
| $5.53M | 0.82% | 0.00% | +12.7% | Q1 2020 | |
| $4.14M | 0.61% | 0.00% | +1.6% | Q4 2019 | |
| PBPMBSPuramed Bioscience Inc. | $4M | 0.59% | 0.04% | +10.0% | Q2 2025 |
| $3.99M | 0.59% | 0.00% | +8.5% | Q4 2019 | |
| $3.31M | 0.49% | Not reported | -3.1% | Q4 2019 | |
| $2.73M | 0.41% | 0.00% | +9.3% | Q4 2024 | |
| $2.6M | 0.39% | 0.00% | -3.2% | Q4 2020 | |
| $2.44M | 0.36% | 0.00% | +11.9% | Q4 2019 | |
| $2.43M | 0.36% | Not reported | +222.8% | Q4 2019 | |
| $2.35M | 0.35% | 0.00% | +42.4% | Q1 2020 | |
| $2.03M | 0.30% | Not reported | +0.3% | Q4 2023 | |
| $1.74M | 0.26% | 0.23% | -3.5% | Q4 2019 | |
| $1.72M | 0.26% | 0.00% | -5.6% | Q4 2021 | |
| $1.65M | 0.25% | 0.00% | -9.0% | Q1 2024 | |
| $1.54M | 0.23% | 0.00% | +15.7% | Q4 2019 | |
| $1.54M | 0.23% | 0.67% | +0.4% | Q4 2025 | |
| $1.45M | 0.22% | 0.00% | +13.9% | Q2 2024 | |
| $1.35M | 0.20% | Not reported | -5.0% | Q4 2019 | |
| $1.32M | 0.20% | 0.00% | +12.9% | Q2 2021 | |
| $1.26M | 0.19% | Not reported | -2.1% | Q4 2019 | |
| $1.25M | 0.19% | 0.00% | +2.5% | Q4 2019 | |
| $1.24M | 0.18% | 0.01% | -7.7% | Q4 2019 | |
| $1.19M | 0.18% | Not reported | +15.7% | Q1 2020 | |
| $1.06M | 0.16% | 0.01% | -6.8% | Q4 2020 | |
| $1.02M | 0.15% | 0.00% | -3.2% | Q1 2020 | |
| $946K | 0.14% | 0.00% | +31.7% | Q2 2025 | |
| $863K | 0.13% | 0.00% | -3.7% | Q4 2019 | |
| $836K | 0.12% | Not reported | -0.4% | Q4 2019 | |
| $765K | 0.11% | 0.00% | +10.6% | Q4 2019 | |
| $736K | 0.11% | 0.00% | +20.7% | Q1 2025 | |
| $671K | 0.10% | 0.00% | Not reported | Q1 2024 | |
| $644K | 0.10% | Not reported | -3.6% | Q4 2019 | |
| $627K | 0.09% | 0.00% | -3.1% | Q3 2021 | |
| $614K | 0.09% | 0.00% | -5.7% | Q1 2021 | |
| $596K | 0.09% | 0.00% | -5.9% | Q1 2021 | |
| $584K | 0.09% | 0.00% | New | Q2 2026 | |
| $541K | 0.08% | 0.00% | -5.9% | Q1 2023 | |
| $541K | 0.08% | 0.00% | -14.1% | Q4 2019 | |
| $537K | 0.08% | 0.00% | -10.1% | Q4 2019 | |
| $524K | 0.08% | 0.00% | +11.6% | Q1 2025 | |
| $522K | 0.08% | 0.00% | Not reported | Q4 2019 | |
| $515K | 0.08% | 0.01% | -7.3% | Q3 2021 | |
| $508K | 0.08% | 0.00% | +6.5% | Q1 2024 | |
| $504K | 0.07% | 0.00% | -16.1% | Q4 2019 | |
| $502K | 0.07% | 0.00% | -18.9% | Q1 2021 | |
| $499K | 0.07% | 0.00% | -6.1% | Q4 2019 | |
| $490K | 0.07% | 0.00% | -9.6% | Q1 2021 | |
| Q1 2026Reported Apr 27, 2026110 positions | |||||
| $11.1M | 1.89% | 3.87% | +9.8% | Q2 2025 | |
| $6.91M | 1.18% | Not reported | +7.3% | Q4 2019 | |
| $4.95M | 0.85% | 0.00% | +5.0% | Q4 2019 | |
| $4.28M | 0.73% | 0.00% | +20.6% | Q1 2020 | |
| PBPMBSPuramed Bioscience Inc. | $3.65M | 0.62% | 0.04% | +17.7% | Q2 2025 |
| $3.65M | 0.62% | 0.00% | +8.5% | Q4 2019 | |
| $3.28M | 0.56% | 0.00% | +0.1% | Q4 2019 | |
| $3.2M | 0.55% | Not reported | -12.3% | Q4 2019 | |
| $2.92M | 0.50% | 0.00% | -49.7% | Q4 2024 | |
| $2.02M | 0.35% | Not reported | +0.2% | Q4 2023 | |
| $1.91M | 0.33% | 0.00% | +9.7% | Q4 2019 | |
| $1.81M | 0.31% | 0.24% | -7.6% | Q4 2019 | |
| $1.54M | 0.26% | 0.01% | -14.7% | Q4 2019 | |
| $1.52M | 0.26% | 0.00% | -9.3% | Q4 2019 | |
| $1.43M | 0.24% | 0.00% | -13.5% | Q4 2020 | |
| $1.35M | 0.23% | 0.00% | +10.4% | Q1 2020 | |
| $1.32M | 0.22% | 0.00% | -19.4% | Q4 2021 | |
| $1.3M | 0.22% | 0.00% | +5.9% | Q1 2024 | |
| $1.26M | 0.21% | 0.67% | +0.9% | Q4 2025 | |
| $1.25M | 0.21% | Not reported | -6.0% | Q4 2019 | |
| $1.18M | 0.20% | 0.00% | +9.4% | Q4 2019 | |
| $1.12M | 0.19% | 0.00% | -2.9% | Q1 2020 | |
| $1.05M | 0.18% | Not reported | -14.2% | Q1 2020 | |
| $1.01M | 0.17% | Not reported | +0.1% | Q4 2019 | |
| $900K | 0.15% | 0.01% | -13.6% | Q4 2020 | |
| $899K | 0.15% | 0.00% | +5.6% | Q2 2021 | |
| $872K | 0.15% | 0.00% | -6.3% | Q4 2019 | |
| $848K | 0.14% | 0.00% | -10.7% | Q2 2024 | |
| $814K | 0.14% | 0.00% | -8.9% | Q2 2024 | |
| $804K | 0.14% | Not reported | +2.1% | Q4 2019 | |
| $656K | 0.11% | Not reported | -67.5% | Q4 2019 | |
| $614K | 0.10% | 0.00% | -12.4% | Q3 2021 | |
| $610K | 0.10% | 0.00% | +10.9% | Q4 2019 | |
| $583K | 0.10% | 0.00% | -29.7% | Q4 2019 | |
| $575K | 0.10% | 0.00% | -4.4% | Q4 2019 | |
| $574K | 0.10% | 0.00% | -19.1% | Q4 2019 | |
| $567K | 0.10% | 0.00% | -9.2% | Q4 2019 | |
| $558K | 0.10% | 0.00% | -15.8% | Q1 2021 | |
| $553K | 0.09% | 0.00% | -12.4% | Q1 2021 | |
| $552K | 0.09% | 0.00% | +4.2% | Q4 2019 | |
| $540K | 0.09% | 0.00% | -8.4% | Q1 2020 | |
| $534K | 0.09% | 0.00% | +6.8% | Q3 2020 | |
| $518K | 0.09% | 0.00% | -11.3% | Q1 2021 | |
| $512K | 0.09% | Not reported | +87.0% | Q4 2019 | |
| $510K | 0.09% | 0.00% | +12.5% | Q1 2025 | |
| $508K | 0.09% | 0.00% | +8.1% | Q2 2025 | |
| $506K | 0.09% | 0.00% | +7.7% | Q4 2023 | |
| $491K | 0.08% | 0.00% | -12.5% | Q1 2023 | |
| $478K | 0.08% | 0.01% | -12.9% | Q3 2021 | |
| $469K | 0.08% | Not reported | -11.4% | Q2 2025 | |
| Q4 2025Reported Feb 5, 2026119 positions | |||||
| $10.7M | 1.85% | 3.53% | +14.0% | Q2 2025 | |
| $6.48M | 1.12% | Not reported | -15.5% | Q4 2019 | |
| $5.35M | 0.92% | 0.01% | +20.6% | Q4 2024 | |
| $5.05M | 0.87% | 0.00% | -0.1% | Q4 2019 | |
| $4.39M | 0.76% | 0.00% | +0.4% | Q4 2019 | |
| $3.79M | 0.65% | 0.00% | +3.9% | Q1 2020 | |
| $3.56M | 0.61% | 0.00% | -3.8% | Q4 2019 | |
| $3.53M | 0.61% | Not reported | -3.9% | Q4 2019 | |
| PBPMBSPuramed Bioscience Inc. | $3.11M | 0.54% | 0.03% | +23.4% | Q2 2025 |
| $2.12M | 0.36% | Not reported | -2.8% | Q4 2019 | |
| $2.08M | 0.36% | 0.02% | +14.5% | Q4 2019 | |
| $2.02M | 0.35% | Not reported | +0.4% | Q4 2023 | |
| $1.97M | 0.34% | 0.26% | -47.4% | Q4 2019 | |
| $1.93M | 0.33% | 0.00% | +4.0% | Q4 2019 | |
| $1.75M | 0.30% | 0.00% | -33.8% | Q4 2021 | |
| $1.6M | 0.28% | 0.00% | -22.4% | Q4 2020 | |
| $1.41M | 0.24% | Not reported | +1.1% | Q1 2020 | |
| $1.37M | 0.24% | 0.00% | +7.9% | Q1 2020 | |
| $1.31M | 0.23% | 0.00% | -1.2% | Q1 2024 | |
| $1.3M | 0.22% | 0.00% | -0.7% | Q4 2019 | |
| $1.3M | 0.22% | Not reported | -7.3% | Q4 2019 | |
| $1.24M | 0.21% | 0.67% | New | Q4 2025 | |
| $1.23M | 0.21% | 0.01% | +44.1% | Q4 2020 | |
| $1.19M | 0.20% | 0.00% | -6.7% | Q4 2019 | |
| $1.07M | 0.18% | Not reported | -3.9% | Q4 2019 | |
| $1.06M | 0.18% | 0.00% | -1.9% | Q4 2019 | |
| $997K | 0.17% | 0.00% | -1.4% | Q1 2020 | |
| $994K | 0.17% | 0.00% | +7.3% | Q2 2021 | |
| $825K | 0.14% | Not reported | -8.9% | Q4 2019 | |
| $811K | 0.14% | 0.00% | -9.2% | Q4 2019 | |
| $798K | 0.14% | 0.00% | -9.3% | Q1 2020 | |
| $769K | 0.13% | 0.00% | -4.9% | Q2 2024 | |
| $746K | 0.13% | 0.00% | +5.6% | Q4 2019 | |
| $743K | 0.13% | 0.00% | -0.9% | Q4 2019 | |
| $678K | 0.12% | 0.00% | -2.5% | Q2 2024 | |
| $656K | 0.11% | 0.00% | -20.9% | Q1 2021 | |
| $652K | 0.11% | 0.01% | -23.6% | Q3 2021 | |
| $638K | 0.11% | 0.00% | -1.8% | Q4 2019 | |
| $623K | 0.11% | 0.00% | +0.9% | Q4 2019 | |
| $622K | 0.11% | 0.01% | -18.7% | Q1 2023 | |
| $573K | 0.10% | 0.00% | -0.4% | Q3 2020 | |
| $552K | 0.10% | 0.00% | -10.0% | Q4 2019 | |
| $550K | 0.09% | 0.00% | -17.5% | Q4 2019 | |
| $532K | 0.09% | 0.00% | -5.1% | Q1 2021 | |
| $525K | 0.09% | 0.00% | -37.8% | Q1 2021 | |
| $522K | 0.09% | 0.00% | -5.4% | Q4 2023 | |
| $511K | 0.09% | 0.00% | -9.5% | Q1 2024 | |
| $509K | 0.09% | 0.00% | -1.2% | Q4 2019 | |
| $506K | 0.09% | 0.00% | -8.7% | Q3 2020 | |
| $498K | 0.09% | 0.00% | -11.4% | Q4 2019 | |
| Q3 2025Reported Nov 4, 2025127 positions | |||||
| $9.26M | 1.67% | 3.09% | +10.6% | Q2 2025 | |
| $7.7M | 1.39% | Not reported | -0.3% | Q4 2019 | |
| $4.74M | 0.85% | 0.00% | -6.3% | Q4 2019 | |
| $4.69M | 0.84% | 0.00% | -6.0% | Q4 2019 | |
| $3.97M | 0.72% | 0.01% | +24.3% | Q4 2024 | |
| $3.76M | 0.68% | 0.50% | -6.6% | Q4 2019 | |
| $3.65M | 0.66% | 0.00% | -5.0% | Q1 2020 | |
| $3.61M | 0.65% | Not reported | -1.8% | Q4 2019 | |
| $2.93M | 0.53% | 0.00% | -14.4% | Q4 2021 | |
| $2.88M | 0.52% | 0.00% | -14.8% | Q4 2019 | |
| PBPMBSPuramed Bioscience Inc. | $2.52M | 0.45% | 0.03% | +97.8% | Q2 2025 |
| $2.19M | 0.39% | 0.00% | -19.7% | Q4 2020 | |
| $2.13M | 0.38% | Not reported | +214.6% | Q4 2019 | |
| $2.02M | 0.36% | Not reported | -12.2% | Q4 2023 | |
| $1.76M | 0.32% | 0.00% | -7.8% | Q4 2019 | |
| $1.55M | 0.28% | Not reported | -5.9% | Q1 2020 | |
| $1.49M | 0.27% | 0.01% | -13.4% | Q4 2019 | |
| $1.38M | 0.25% | Not reported | -1.3% | Q4 2019 | |
| $1.3M | 0.23% | 0.00% | -5.3% | Q4 2019 | |
| $1.22M | 0.22% | 0.00% | +4.5% | Q1 2024 | |
| $1.21M | 0.22% | 0.00% | -6.0% | Q1 2020 | |
| $1.19M | 0.21% | 0.00% | +1.2% | Q4 2019 | |
| $1.09M | 0.20% | Not reported | -1.4% | Q4 2019 | |
| $1.08M | 0.20% | 0.00% | -0.5% | Q1 2020 | |
| $1.08M | 0.19% | 0.00% | -7.8% | Q4 2019 | |
| $1.04M | 0.19% | 0.01% | -14.3% | Q4 2020 | |
| $906K | 0.16% | Not reported | -4.1% | Q4 2019 | |
| $891K | 0.16% | 0.00% | -27.8% | Q4 2019 | |
| $879K | 0.16% | 0.01% | -16.0% | Q3 2021 | |
| $866K | 0.16% | 0.00% | -11.7% | Q1 2020 | |
| $845K | 0.15% | 0.00% | +59.6% | Q4 2019 | |
| $814K | 0.15% | 0.00% | -6.0% | Q2 2023 | |
| $813K | 0.15% | 0.00% | -8.1% | Q4 2019 | |
| $809K | 0.15% | 0.00% | +6.8% | Q1 2020 | |
| $803K | 0.14% | 0.00% | -15.6% | Q1 2021 | |
| $800K | 0.14% | 0.00% | -25.5% | Q4 2021 | |
| $797K | 0.14% | Not reported | -7.7% | Q2 2025 | |
| $785K | 0.14% | 0.00% | -13.4% | Q4 2019 | |
| $752K | 0.14% | 0.01% | -16.7% | Q1 2023 | |
| $732K | 0.13% | 0.00% | -3.1% | Q2 2024 | |
| $730K | 0.13% | 0.00% | -16.6% | Q1 2021 | |
| $725K | 0.13% | 0.00% | -15.0% | Q1 2021 | |
| $711K | 0.13% | 0.00% | -27.0% | Q2 2024 | |
| $705K | 0.13% | 0.00% | +1.4% | Q4 2020 | |
| $694K | 0.13% | 0.00% | +3.3% | Q4 2019 | |
| $658K | 0.12% | 0.00% | +7.2% | Q2 2021 | |
| $636K | 0.11% | 0.00% | -15.4% | Q1 2021 | |
| $633K | 0.11% | 0.00% | -7.7% | Q4 2019 | |
| $629K | 0.11% | 0.00% | -17.4% | Q1 2023 | |
| $617K | 0.11% | 0.00% | -21.5% | Q4 2019 | |
Premium opens every quarter this fund has filed